Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer

<div>Pan-cancer analysis showed MRPL13 was correlated to OS and TMB levels in human cancers. (a) Pan-cancer analysis showed MRPL13 was correlated to OS in human cancers. (b) Pan-cancer analysis showed MRPL13 was correlated to TMB levels in human cancers.</div>

Computational and Mathematical Methods in Medicine

fig8

Figure 8

Figure 8: Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer 

Figure 8 | Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer 